Acceptability of Digital Health Technologies in Early Parkinson's disease (PD)

被引:0
|
作者
Kangarloo, T.
Latzman, R.
Adams, J.
Dorsey, E.
Kostrzebski, M.
Anderson, D.
Horak, F.
Stephenson, D.
Cosman, J.
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
1228
引用
收藏
页码:S571 / S571
页数:1
相关论文
共 50 条
  • [21] Early Prediction of Parkinson's Disease (PD) Using Ensemble Classifiers
    Anisha, C. D.
    Arulanand, N.
    2020 INTERNATIONAL CONFERENCE ON INNOVATIVE TRENDS IN INFORMATION TECHNOLOGY (ICITIIT), 2020,
  • [22] Rasagiline provides symptomatic benefit in early Parkinson's disease (PD)
    Jankovic, J.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S127 - S128
  • [23] Clinical Profile of Early-Onset Parkinson's disease (PD)
    Pena Martinez, S.
    Ayala Minero, R.
    Amaya, R.
    Medina Escobar, A.
    Salles, P.
    MOVEMENT DISORDERS, 2024, 39 : S234 - S234
  • [24] Cognitive effects of safinamide in early Parkinson's disease (PD) patients
    Sharma, T.
    Anand, R.
    Stocchi, F.
    Borgohain, R.
    Rossetti, S.
    MOVEMENT DISORDERS, 2007, 22 : S236 - S237
  • [25] AccessParkinson's disease (PD) Registry Update: Accelerating Parkinson's disease (PD) Research Through Integrated Digital Solutions
    Chang, Y. -H.
    Perinan, M.
    Noyce, A.
    MOVEMENT DISORDERS, 2024, 39 : S316 - S316
  • [26] Pharmacotherapy in the management of early Parkinson's disease: cost-effectiveness and patient acceptability
    Cubo, Esther
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2010, 2 : 127 - 134
  • [27] WATCH-PD2: A Remote Extension Digital Measures Study in Early Parkinson's disease (PD): Study Design and Status Update
    Adams, J.
    Lerner, A.
    Al-Rubayie, R.
    Kangarloo, T.
    Gong, Y.
    Khachadourian, V.
    Tracey, B.
    Volfson, D.
    Lazman, R.
    Cosman, J.
    Edgerton, J.
    Anderson, D.
    Best, A.
    Kostrzebski, M.
    Auinger, P.
    Tarolli, C.
    Mueller, M.
    Stephenson, D.
    Dorsey, E.
    MOVEMENT DISORDERS, 2024, 39 : S322 - S322
  • [28] Enabling efficient use of digital health technologies to support Parkinson's disease drug development through precompetitive collaboration
    Cedarbaum, J.
    Taylor, K.
    Hill, D.
    Alexander, R.
    Luo, Y.
    Rubens, R.
    Zach, N.
    Cosman, J.
    Dowling, A.
    Fisher, K.
    Oliva, L.
    Hitchcock, J.
    Lawton, M.
    Conrado, D.
    Romero, K.
    Minchik, M.
    Meulien, D.
    Yang, B.
    Forman, M.
    Bataille, L.
    Dexter, D.
    Gallagher, J.
    Braxenthaler, M.
    Lindemann, M.
    Boroojerdi, B.
    Stebbins, G.
    Bloem, B.
    Hu, M.
    Dorsey, E.
    Stephenson, D.
    MOVEMENT DISORDERS, 2019, 34 : S33 - S34
  • [29] Parkinson's disease (PD) and hypoxia
    Appenzeller, O
    Serebrovskaya, T
    Karaban, I
    Mankovskaya, I
    Bernardi, L
    Passino, C
    NEUROLOGY, 1997, 48 (03) : 38001 - 38001
  • [30] Pain in Parkinson's disease (PD)
    Kirtaev, S.
    Litvinenko, I.
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 249 - 250